EUVIMEDEUVIMED entdecken
Crossref

Long-term impact of an antimicrobial stewardship programme on antimicrobial use and selected clinical outcomes: A 15-year interrupted time series study

Manuel Crespo-Casal, Maria Antònia Balet-Duat, Lucia Canino-Aguado, Gloria Trujillo-Isern, Antonia Flor-Perez, Naiara Villalba-Blanco, Miquel Micó-Garcia, Belen Jufresa-Michavila, Joan Lopez-Madueño, Rafel Perez-Vidal

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2026-11 · 44 (9) · 503259

DOI: 10.1016/j.eimce.2026.503259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2026-11. Verfasst von Manuel Crespo-Casal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit - Internal Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Barcelona, Spain; Institut de Recerca i Innovació …. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate the long-term impact of an antimicrobial stewardship programme (ASP) based on prospective audit and feedback on antimicrobial use and selected clinical outcomes. METHODS: We conducted a single-centre interrupted time series analysis evaluating antimicrobial use before (2008-2016) and after (2017-2023) implementation of an audit-and-feedback-based ASP. Consumption was expressed as defined-daily-doses per 100 occupied bed-days (DDD/100 OBD). The model included ASP implementation and COVID-19 onset in 2020. Trends were benchmarked against the VINCat surveillance network. Secondary analyses included incidence density of multidrug-resistant bloodstream-infections (BSI) and 14-day associated mortality, methicillin-resistant Staphylococcus aureus (MRSA) and Clostridioides difficile infection (CDI). RESULTS: ASP implementation was associated with significant reductions in piperacillin/tazobactam consumption -1.40 DDD/100 OBD (95% CI -2.47 to -0.33) and a non-significant decrease in carbapenem use, accompanied by increased use of narrower-spectrum antipseudomonal cephalosporins. Although a sustained decrease in total antimicrobial use was not achieved, trends were more favourable than in VINCat hospitals (annual slope difference -0.64 DDD/100 OBD; 95% CI -1.21 to -0.065). No significant changes were observed in multidrug-resistant BSI incidence or 14-day mortality. MRSA incidence decline during the study period, while CDI incidence remained stable. CONCLUSIONS: This audit-and-feedback-based ASP was associated with sustained shifts towards narrower-spectrum antimicrobial use and more favourable consumption trends compared with peer hospitals. However, no significant reductions in overall antimicrobial use or key clinical outcomes were observed, highlighting the challenges of achieving measurable clinical impact in real-world hospital settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipAnti-Bacterial AgentsInterrupted Time Series AnalysisHumansDrug UtilizationTime FactorsProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Antibiotic consumptionAntimicrobial resistanceAntimicrobial stewardshipBacteriemiaBloodstream infectionConsumo de antimicrobianosEpidemiologia hospitalariaHospital epidemiologyInterrupted time seriesOptimización uso antibióticosResistencia antimicrobianaSerie temporal interrumpida

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Infectious Diseases Unit - Internal Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Barcelona, Spain; Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS-CC),…
  • Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS-CC), Barcelona, Spain; Pharmacy Service, Althaia Xarxa Assistencial Universitària de Manresa, Barcelona, Spain.
  • Universitat de Vic - Universitat Central de Catalunya, Facultat de Medicina, Vic, Spain.
  • Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS-CC), Barcelona, Spain; Microbiology Unit, Althaia Xarxa Assistencial Universitària de Manresa, Barcelona, Spain.

Zitieren

APA

Crespo-Casal, M., Balet-Duat, M. A., Canino-Aguado, L., Trujillo-Isern, G., Flor-Perez, A., Villalba-Blanco, N., Micó-Garcia, M., Jufresa-Michavila, B., Lopez-Madueño, J., & Perez-Vidal, R. (2026). Long-term impact of an antimicrobial stewardship programme on antimicrobial use and selected clinical outcomes: A 15-year interrupted time series study. Enfermedades infecciosas y microbiologia clinica (English ed.), 44(9), 503259. https://doi.org/10.1016/j.eimce.2026.503259

Vancouver

Crespo-Casal M, Balet-Duat MA, Canino-Aguado L, Trujillo-Isern G, Flor-Perez A, Villalba-Blanco N, et al. Long-term impact of an antimicrobial stewardship programme on antimicrobial use and selected clinical outcomes: A 15-year interrupted time series study. Enfermedades infecciosas y microbiologia clinica (English ed.). 2026;44(9):503259. doi:10.1016/j.eimce.2026.503259

BibTeX
@article{CrespoCasal2026,
  author = {Crespo-Casal, Manuel and Balet-Duat, Maria Antònia and Canino-Aguado, Lucia and Trujillo-Isern, Gloria and Flor-Perez, Antonia and Villalba-Blanco, Naiara and Micó-Garcia, Miquel and Jufresa-Michavila, Belen and Lopez-Madueño, Joan and Perez-Vidal, Rafel},
  title = {Long-term impact of an antimicrobial stewardship programme on antimicrobial use and selected clinical outcomes: A 15-year interrupted time series study},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2026},
  volume = {44},
  number = {9},
  pages = {503259},
  doi = {10.1016/j.eimce.2026.503259}
}
Kostenlos starten →